Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 445Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
ORIGINAL ARTICLE
Year : 2013  |  Volume : 4  |  Issue : 4  |  Page : 221-226

A data-driven approach to quality risk management


Specialty Care Business Unit, Clinical Affairs, Statistics (DA, JA, ML) and Worldwide Research & Development, Clinical Quality Management (DN), Pfizer, Inc., New York, USA

Correspondence Address:
Jose Alvir
Pfizer, Inc., 235 East 42nd Street, NYO-219-07-01, New York, NY 10017
USA
Login to access the Email id

Source of Support: The authors conducted this study as employees of Pfizer, Inc,, Conflict of Interest: All of the authors are employees of Pfizer, Inc.


DOI: 10.4103/2229-3485.120171

Rights and Permissions

Aim: An effective clinical trial strategy to ensure patient safety as well as trial quality and efficiency involves an integrated approach, including prospective identification of risk factors, mitigation of the risks through proper study design and execution, and assessment of quality metrics in real-time. Such an integrated quality management plan may also be enhanced by using data-driven techniques to identify risk factors that are most relevant in predicting quality issues associated with a trial. In this paper, we illustrate such an approach using data collected from actual clinical trials. Materials and Methods: Several statistical methods were employed, including the Wilcoxon rank-sum test and logistic regression, to identify the presence of association between risk factors and the occurrence of quality issues, applied to data on quality of clinical trials sponsored by Pfizer. Results: Only a subset of the risk factors had a significant association with quality issues, and included: Whether study used Placebo, whether an agent was a biologic, unusual packaging label, complex dosing, and over 25 planned procedures. Conclusion: Proper implementation of the strategy can help to optimize resource utilization without compromising trial integrity and patient safety.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1829    
    Printed51    
    Emailed0    
    PDF Downloaded342    
    Comments [Add]    
    Cited by others 1    

Recommend this journal